On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on “competitive pressure in its business.”
Following this news, Treace’s stock price fell by $6.95 per share, or approximately 62% on the same day.
To receive more information, please fill out the form.
